DEF 14A: Nexalin Technology Sets Date for Annual Stockholder Meeting, Proposes Equity Plan Amendment

Nexalin Technology will hold its annual stockholder meeting virtually on August 26, 2024, to elect directors, approve an equity incentive plan amendment, and ratify the appointment of independent auditors.

Summary

• Nexalin Technology will hold its Annual Meeting of Stockholders virtually on August 26, 2024, at 10:00 a.m. Eastern Standard Time.
• Stockholders of record as of July 17, 2024, are entitled to notice of and to vote at the Annual Meeting.
• The meeting will cover the election of five directors, approval of an amendment to the Company's 2023 Equity Incentive Plan, and ratification of the appointment of Marcum LLP as the Company's independent auditors for the fiscal year ending December 31, 2024.
• The Board of Directors recommends voting for the election of each director nominee, for the approval of the amendment to the 2023 Equity Incentive Plan, and for the ratification of the appointment of the independent auditors.
• The company is soliciting proxies for the meeting and encourages stockholders to vote via the internet, telephone, or mail.
• The proxy materials are available online at https://www.cstproxy.com/nexalin/2024.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, so the sentiment is neutral to slightly positive due to the routine nature of the information and the board's recommendations.

Positives

• The virtual meeting format aims to enable more stockholders to attend and participate.
• The Board believes that the segregation of the roles of Board Chairman and the Chief Executive Officer ensures better overall governance of the Company and provides meaningful checks and balances regarding its overall performance.
• The company has established a process to receive communications from stockholders.

Risks

• The Board recognizes that all companies face a variety of risks, including, liquidity/capital accessibility risk, medical product acceptance risk, and operational risk and, in the Company's case, China operation risk.

Future Outlook

The company aims to attract and retain qualified managers and promote an ownership mentality among key leadership and the Board of Directors.

Management Comments

• The Board believes that the segregation of the roles of Board Chairman and the Chief Executive Officer ensures better overall governance of the Company and provides meaningful checks and balances regarding its overall performance.
• The Company also believes that having separate positions provides a clear delineation of responsibilities for each position and fosters greater accountability of management.

Industry Context

Proxy statements are standard documents for publicly traded companies, providing transparency and enabling shareholder participation in corporate governance.

Comparison to Industry Standards

• The structure of the board and its committees (Audit, Compensation, Nominating) aligns with standard corporate governance practices for NASDAQ-listed companies.
• The compensation packages for executives and directors are designed to be competitive within the health technology industry to attract and retain talent.
• The virtual-only format for the annual meeting is a growing trend among companies to increase accessibility and reduce costs.

Related Party Transactions

• The Company has a consulting agreement with U.S. Asian Consulting Group, LLC, whose members are shareholders in the Company.
• The Company leases office space through IIcom Strategic Inc. controlled and owned by our Chief Executive Officer.

Stakeholder Impact

• Shareholders will be able to vote on key company decisions.
• Employees may be affected by changes to the equity incentive plan.
• The appointment of independent auditors ensures financial transparency for all stakeholders.

Next Steps

• Stockholders are urged to vote on the proposals outlined in the proxy statement.
• The company will hold the Annual Meeting of Stockholders on August 26, 2024.
• The Board will consider the outcome of the votes on the proposals.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Directors, Equity Incentive Plan, Independent Auditors, Marcum LLP, Nexalin Technology